Multidisciplinary Interventional Oncology
Academic Press
Will be published approx. on 1. July 2027
Book
Paperback/Softback
900 pages
978-0-443-45946-7 (ISBN)
Description
Multidisciplinary Interventional Oncology explores interventional oncology (IO) as the fourth pillar of cancer care alongside surgery, radiation, and medical oncology. The book highlights IO's minimally invasive, image-guided techniques, offering reduced morbidity and toxicity. It aims to establish IO as a key modality in managing malignancies like liver cancer, integrating emerging technologies and enhancing multidisciplinary collaboration. Authored by leading interventional radiologists, the book covers a wide range of IO therapies, emphasizing multidisciplinary cancer care that combines IO with systemic treatments. Each chapter presents current evidence, referencing clinical guidelines and trials while also showcasing advancements and novel devices to address knowledge gaps and procedural uncertainties.
For academics, the book provides access to the latest innovations and fosters precision-driven oncologic care. It promotes interdisciplinary collaboration, equipping readers with the knowledge and tools necessary to advance cancer care and meeting the growing demands for integration and educational resources in interventional oncology.
For academics, the book provides access to the latest innovations and fosters precision-driven oncologic care. It promotes interdisciplinary collaboration, equipping readers with the knowledge and tools necessary to advance cancer care and meeting the growing demands for integration and educational resources in interventional oncology.
More details
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
Product notice
Paperback (trade)
Unsewn / adhesive bound
Dimensions
Height: 235 mm
Width: 191 mm
ISBN-13
978-0-443-45946-7 (9780443459467)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Persons
Dr. Teng is a pioneer of interventional radiology in China, with over 40 years of experience in clinical practice, research, and education. He has introduced significant innovations in interventional oncology, including novel stents coated with ^125I radioactive seeds for treating esophageal, biliary, airway, and liver cancers, leading to seven randomized controlled trials. A prolific scholar, Dr. Teng has published over 500 papers, including more than 300 in prestigious journals, and holds over 40 patents. He has trained over 500 residents, fellows, and Ph.D. students globally. In 2021, he was elected to the Chinese Academy of Sciences, becoming the first radiologist to achieve this honor. Dr. Teng is a Fellow of the Society of Interventional Radiology (SIR) and the Cardiovascular and Interventional Radiology Society of Europe (CIRSE), receiving numerous accolades, including the Distinguished Fellow Award of CIRSE and the Gold Medal of SIR. He is the Founding President of the International Society of Multidisciplinary and Interventional Oncology (ISMIO).
Dr. David C. Madoff is a Professor at Yale School of Medicine, where he is Vice Chair for Clinical Research and Section Chief of Interventional Radiology. Board-certified in Diagnostic Radiology and Vascular and Interventional Radiology, he previously spent a decade at MD Anderson Cancer Center and later served as Division Chief of Interventional Radiology at Weill Cornell Medical Center before joining Yale in 2019.
Dr. Madoff is renowned for his pioneering work in Interventional Oncology, particularly in preoperative portal vein embolization to enhance liver resection for cancer patients. His expertise includes hepatobiliary, genitourinary, and vascular interventions, as well as advanced biopsy and ablation techniques.
An active leader in academic radiology, he has authored over 220 peer-reviewed articles and held editorial roles, including Deputy Editor-in-Chief of the Journal of Vascular and Interventional Radiology. Dr. Madoff is a Fellow of several prestigious societies and has received Honorary Membership in the Chinese College of Interventionalists, highlighting his global influence.
Dr. David C. Madoff is a Professor at Yale School of Medicine, where he is Vice Chair for Clinical Research and Section Chief of Interventional Radiology. Board-certified in Diagnostic Radiology and Vascular and Interventional Radiology, he previously spent a decade at MD Anderson Cancer Center and later served as Division Chief of Interventional Radiology at Weill Cornell Medical Center before joining Yale in 2019.
Dr. Madoff is renowned for his pioneering work in Interventional Oncology, particularly in preoperative portal vein embolization to enhance liver resection for cancer patients. His expertise includes hepatobiliary, genitourinary, and vascular interventions, as well as advanced biopsy and ablation techniques.
An active leader in academic radiology, he has authored over 220 peer-reviewed articles and held editorial roles, including Deputy Editor-in-Chief of the Journal of Vascular and Interventional Radiology. Dr. Madoff is a Fellow of several prestigious societies and has received Honorary Membership in the Chinese College of Interventionalists, highlighting his global influence.
Editor
SouthEast University, Nanjing, China
Yale School of Medicine, USA
Content
Part I: Interventional Oncology: General Principles
1. Evolution of Interventional Oncology
2. Fundamentals and Principles of Interventional Oncology
3. Tumor Ablation Techniques
4. Transarterial Therapies
5. Non-Interventional Techniques: Biopsy, Drainage, Stenting
6. Vascular Interventional Techniques Related to Tumors
7. Multidisciplinary Care Coordination
8. Patient Selection and Risk Stratification
9. Complications and Perioperative Management
10. Ethical and Regulatory Considerations
11. Building an Interventional Oncology Program
12. Prospective of Interventional Oncology
Part II: Interventional Oncology in Specific Diseases
1. Primary Liver Cancer
2. Liver Metastases
3. Lung Cancer and Respiratory System
4. Nervous System
5. Urogenital System
6. Musculoskeletal System
7. Vascular and Lymphatic System
8. Endocrine System
9. ENT (Ear, Nose, and Throat)
10. Miscellaneous
1. Evolution of Interventional Oncology
2. Fundamentals and Principles of Interventional Oncology
3. Tumor Ablation Techniques
4. Transarterial Therapies
5. Non-Interventional Techniques: Biopsy, Drainage, Stenting
6. Vascular Interventional Techniques Related to Tumors
7. Multidisciplinary Care Coordination
8. Patient Selection and Risk Stratification
9. Complications and Perioperative Management
10. Ethical and Regulatory Considerations
11. Building an Interventional Oncology Program
12. Prospective of Interventional Oncology
Part II: Interventional Oncology in Specific Diseases
1. Primary Liver Cancer
2. Liver Metastases
3. Lung Cancer and Respiratory System
4. Nervous System
5. Urogenital System
6. Musculoskeletal System
7. Vascular and Lymphatic System
8. Endocrine System
9. ENT (Ear, Nose, and Throat)
10. Miscellaneous